Skip to main content
Clinical Trials/NCT05961657
NCT05961657
Recruiting
N/A

Hemodynamic Evaluation in Preterm Babies Using UltraSonic Cardiac Output Monitor (USCOM)

Fondazione IRCCS San Gerardo dei Tintori1 site in 1 country80 target enrollmentJuly 6, 2023

Overview

Phase
N/A
Intervention
Not specified
Conditions
Very Low Birth Weight Infant
Sponsor
Fondazione IRCCS San Gerardo dei Tintori
Enrollment
80
Locations
1
Primary Endpoint
Cardiac Output at 7 days
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

The goal of this observational study is to learn about the feasibility of hemodynamic measurement by the UltraSonic Cardiac Output Monitor (USCOM) in very preterm or very-low-birth-weight infants. The main questions it aims to answer are: 1) establishing reference ranges for USCOM parameters in this specific population, 2) assessing the effect of patients' characteristics and other possible confounders on USCOM parameters, and 3) evaluating the short-term repeatability of the measurement. Participants will receive USCOM measurements on 3, 7, and 14 postnatal days.

Registry
clinicaltrials.gov
Start Date
July 6, 2023
End Date
September 1, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Fondazione IRCCS San Gerardo dei Tintori
Responsible Party
Principal Investigator
Principal Investigator

Daniela Doni

Consultant Neonatologist

Fondazione IRCCS San Gerardo dei Tintori

Eligibility Criteria

Inclusion Criteria

  • gestational age at birth below 32 weeks and/or
  • birth weight (BW) below 1500 g

Exclusion Criteria

  • congenital heart diseases,
  • hemodynamic instability requiring drugs that affect hemodynamics (e.g., inotropes)

Outcomes

Primary Outcomes

Cardiac Output at 7 days

Time Frame: 7 ± 2 days of life

Cardiac Output measured by the USCOM system, normalized by body weight and expressed in ml/kg/min

Systemic Vascular Resistance Index at 14 days

Time Frame: 14 ± 2 days of life

Systemic Vascular Resistance measured by the USCOM system normalized by body surface and expressed in d\*s\*cm-5/m2

Cardiac Output at 14 days

Time Frame: 14 ± 2 days of life

Cardiac Output measured by the USCOM system, normalized by body weight and expressed in ml/kg/min

Cardiac Index at 3 days

Time Frame: 3 ± 1 days of life

Cardiac Output measured by the USCOM system normalized by body surface and expressed in L/min/m2

Cardiac Index at 7 days

Time Frame: 7 ± 2 days of life

Cardiac Output measured by the USCOM system normalized by body surface and expressed in L/min/m2

Systemic Vascular Resistance Index at 3 days

Time Frame: 3 ± 1 days of life

Systemic Vascular Resistance measured by the USCOM system normalized by body surface and expressed in d\*s\*cm-5/m2

Cardiac Index at 14 days

Time Frame: 14 ± 2 days of life

Cardiac Output measured by the USCOM system normalized by body surface and expressed in L/min/m2

Systemic Vascular Resistance Index at 7 days

Time Frame: 7 ± 2 days of life

Systemic Vascular Resistance measured by the USCOM system normalized by body surface and expressed in d\*s\*cm-5/m2

Cardiac Output at 3 days

Time Frame: 3 ± 1 days of life

Cardiac Output measured by the USCOM system, normalized by body weight and expressed in ml/kg/min

Study Sites (1)

Loading locations...

Similar Trials